Bank of New York Mellon Corp
BankPosition in ELVN — Enliven Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in ELVN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,031,788
+$1,325,555 QoQ
Shares Held
118,853
-1.0% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ELVN ranks #88 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ELVN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,031,788 | 118,853 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $4,706,233 | 120,057 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,702,761 | 110,569 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,366,657 | 115,616 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,968,467 | 98,129 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,841,397 | 93,567 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,015,437 | 89,575 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,308,892 | 90,403 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,666,725 | 114,109 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,345,229 | 76,477 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,108,984 | 80,129 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,103,167 | 80,759 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,651,658 | 80,924 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $334,960 | 15,295 | Shares | Defined | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||